Combined Effects of Pain Interference and Depressive Symptoms on Dementia Incidence: A 36-Month Follow-Up Study.

Journal of Alzheimer's Disease : JAD
Keitaro MakinoHiroyuki Shimada

Abstract

Both pain interference and depressive symptoms have certain effects on dementia, and these are reciprocally related. However, comorbid effects of pain interference and depressive symptoms on dementia have not been examined in detail. This longitudinal study aimed to examine the combined effects of pain interference and depressive symptoms on the incidence of dementia in community-dwelling elderly individuals. This prospective cohort study with a 36-month follow-up period included 4,326 community-dwelling elderly individuals without dementia at baseline. Pain interference and depressive symptoms were assessed for every participant at baseline. We collected medical records in the Japanese public health insurance system to identify the incidence of dementia for 36 months. The incidence rates of dementia during the follow-up period in the control, pain-interference, depressive-symptoms, and comorbid group were 3.2%, 6.2%, 7.9%, and 11.3%, respectively. A Cox regression analysis showed that the hazard ratios for the incidence of dementia were 1.85 (95% CI: 1.13-3.03) in the pain interference group, 1.87 (95% CI: 1.27-2.76) in the depressive symptoms group, and 2.20 (95% CI: 1.26-3.84) in the comorbid group, after adjusting for covar...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jul 1, 1983·Archives of General Psychiatry·M F FolsteinJ E Helzer
Feb 13, 2001·Pain·F M BlythM J Cousins
Dec 4, 2001·Pain·J M Grisart, M Van der Linden
Oct 16, 2002·Nature Neuroscience·Mark W GilbertsonRoger K Pitman
Nov 12, 2003·Archives of Internal Medicine·Matthew J BairKurt Kroenke
May 26, 2004·Lancet Neurology·Laura FratiglioniBengt Winblad
Apr 11, 2009·Journal of Pain and Symptom Management·Francesco LandiGraziano Onder
Apr 9, 2010·Journal of the American Geriatrics Society·Sebastian KöhlerJudith Allardyce
Jan 20, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S S PathanA Alonso
May 4, 2011·Nature Reviews. Neurology·Amy L Byers, Kristine Yaffe
May 4, 2011·International Journal of Geriatric Psychiatry·Jing YuZhenyun Wu
Jul 13, 2012·Alzheimer's Research & Therapy·Rianne M van der LindeCarol Brayne
Jan 4, 2013·The British Journal of Psychiatry : the Journal of Mental Science·Pim CuijpersBrenda W Penninx
May 15, 2013·Journal of the American Medical Directors Association·Hiroyuki ShimadaTakao Suzuki
May 16, 2014·Journal of Alzheimer's Disease : JAD·Minna RusanenTiia Ngandu
Jul 30, 2014·Current Opinion in Neurobiology·Benjamin K Lau, Christopher W Vaughan
Oct 28, 2014·International Journal of Geriatric Psychiatry·Pilar Laborde-LahozRobert H Pietrzak
May 9, 2015·Geriatrics & Gerontology International·Hiroyuki ShimadaTakao Suzuki
Apr 1, 2006·Acta Neuropsychiatrica·Lana J WilliamsMichael Berk
May 22, 2016·Archives of Physical Medicine and Rehabilitation·Susan L MurphyAnna L Kratz
Jun 7, 2017·Journal of Alzheimer's Disease : JAD·Takehiko DoiTakao Suzuki
Jun 7, 2017·JAMA Internal Medicine·Elizabeth L WhitlockAlexander K Smith
Jul 25, 2017·Lancet·Gill LivingstonNaaheed Mukadam
Sep 28, 2017·Journal of the American Geriatrics Society·Takahiro NakamuraYuji Nishiwaki
Sep 12, 2018·Journal of Clinical Medicine·Hiroyuki ShimadaHidenori Arai
Nov 20, 2018·Gerontology & Geriatric Medicine·Shunsuke MurataRei Ono
Dec 14, 2018·Current Alzheimer Research·Ali EzzatiRichard B Lipton
Dec 19, 2018·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Keitaro MakinoHiroyuki Shimada
Jan 12, 2019·Journal of Geriatric Psychiatry and Neurology·Ali EzzatiRichard B Lipton
May 17, 2019·Medicine and Science in Sports and Exercise·Kirk I EricksonUNKNOWN FOR 2018 PHYSICAL ACTIVITY GUIDELINES ADVISORY COMMITTEE*
Nov 5, 2019·Journal of Pain and Symptom Management·Sophie PaskJason W Boland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.